Neurosurgeons at UC San Diego Moores Cancer Center are among the first in the world to utilize real-time MRI guidance for delivery of gene therapy as a potential treatment for brain tumors. Using MRI, neurosurgeons can inject Toca 511, a novel investigational gene therapy directly into a brain malignancy such as glioblastoma.